Jenscare Scientific Co., Ltd.
HKSE: 9877.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Fei Pan
- Employees
- 211
- Headquarters
- Ningbo, China
- IPO year
- 2022
- Market cap
- HK$4.0B
- Website
- https://www.jenscare.com
Loading 9877…
Loading profile data…Frequently asked questions about 9877
What does Jenscare Scientific Co., Ltd. (9877.HK) do?
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitati...
Where does 9877.HK trade?
Jenscare Scientific Co., Ltd. (9877.HK) trades on the Hong Kong Stock Exchange.
What sector is 9877.HK in?
Jenscare Scientific Co., Ltd. (9877.HK) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Jenscare Scientific Co., Ltd.?
Fei Pan is the chief executive officer of Jenscare Scientific Co., Ltd. (9877.HK).
Where is Jenscare Scientific Co., Ltd. headquartered?
Jenscare Scientific Co., Ltd. is headquartered in China.
Does 9877.HK pay a dividend?
Jenscare Scientific Co., Ltd. (9877.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 9877.HK go public?
Jenscare Scientific Co., Ltd. (9877.HK) completed its initial public offering in 2022.